Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
3 studies found for:    3156006 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Not yet recruiting Clinical Study of the Boston Scientific Paclitaxel-Coated PTA(Percutaneous Transluminal Angioplasty) Balloon Catheter (Ranger™ and Ranger™ SL (OTW) DCB) in China
Condition: Femoropopliteal Artery Lesions
Intervention: Device: Boston Scientific Ranger™ and Ranger™ SL Paclitaxel-Coated PTA Balloon Catheter
2 Recruiting Novel Treatment of Intermittent Claudication in Patients With Peripheral Arterial Disease Using Danshen Gegen (D&G) Capsule
Conditions: Peripheral Arterial Disease;   Intermittent Claudication
Interventions: Drug: Danshen Gegen Capsule;   Drug: Placebo
3 Completed Etiology and Prevalence of Peripheral Arterial Disease
Conditions: Cardiovascular Diseases;   Peripheral Vascular Diseases;   Arterial Occlusive Diseases

Indicates status has not been verified in more than two years